Trypanosoma brucei: Lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites

Experimental Parasitology

Volumn 86, Issue 3, 1997, Pages 181-190

  Scott, Alan G ^a   Tait, Andy ^a   Turner, C Michael R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adduct of melarsen and trypanothione (melT); Adenosine transporter; African trypanosome; Carter's balanced salt solution (CBSS); Cymelarsan (melCy); Drug resistance; Melaminophenyl arsenical; Melarsen oxide (melOx); Melarsoprol (melB); Phenyl arsenoxide (PhAsOx); Trimelarsen (melW)

Indexed keywords

DIAMIDINE DERIVATIVE; DIMINAZENE ACETURATE; MELARSAMINE; MELARSOPROL; PENTAMIDINE;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CROSS RESISTANCE; CYTOLYSIS; DATA ANALYSIS; ELECTRON TRANSPORT; HOST PARASITE INTERACTION; LIPID SOLUBILITY; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI; TRYPANOSOMA RHODESIENSE;

TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 0031194833     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4167     Document Type: Article

References (27)

1. Barrett, M. P., Zhang, Z. Q., Denise, H., Giroud, C., and Baltz, T. 1995. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Molecular and Biochemical Parasitology 73, 223-229.
2. Berger, B. J., and Fairlamb, A. H. 1994. Properties of melarsamine hydrochloride (cymelarsan) in aqueous solution. Antimicrobial Agents and Chemotherapy 38, 1298-1302.
3. Berger, B. J., Carter, N. S., and Fairlamb, A. H. 1995. Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Molecular and Biochemical Parasitology 69, 289-298.
4. Brun, R., and Schonenberger, M. 1979. Cultivation and in vitro cloning of procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Acta Tropica 36, 289-292.
5. Burri, C., Baltz, T, Giroud, C., Doua, F., Welker, H. A., and Brun, R. 1993. Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy 39, 225-234.
6. Carter, N. S., and Fairlamb, A. H. 1993. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361, 173-175.
7. Carter, N. S., Berger, B. J., and Fairlamb, A. H. 1995. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and-resistant Trypanosoma brucei brucei. The Journal of Biological Chemistry 270, 28153-28157.
8. De Jongh, R. T., and Friedheim, E. A. H. 1959. Le pentylthiarsphényl-mélamine (melW) dans le traitement de trypanosomiase à T. gambiense. Bulletin de la Socief Pathologie Exotique 52, 769.
9. Fairlamb, A. H., Henderson, G. B., and Cerami, A. 1989. Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proceedings of the National Academy of Sciences of the United States of America 86, 2607-2611.
10. Fairlamb, A. H., Carter, N. S., Cunningham, M., and Smith, K. 1992a. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Molecular and Biochemical Parasitology 53, 213-222.
11. Fairlamb, A. H., Smith, K., and Hunter, K. J. 1992b. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Molecular and Biochemical Parasitology 53, 223-232.
12. Friedheim, E. A. H. 1948. Melarsen oxide in the treatment of human trypanosomiasis. Annals of Tropical Medicine 18, 357-363.
13. Friedheim, E. A. H. 1949. MelB in the treatment of human trypanosomiasis. American Journal of Tropical Medicine 29, 173-180.
14. Frommel, T. O., and Balber, A. E. 1987. Flow cytofluorimetric analysis of drug accumulation by multi drug-resistant Trypanosoma brucei brucei and T. b. rhodesiense. Molecular and Biochemical Parasitology 26, 183-191.
15. Herbert, W. J., and Lumsden, W. H. R. 1976. Trypanosoma brucei: A rapid "matching" method for estimating the host's parasitaemia. Experimental Parasitology 40, 427-431.
16. Lanham, S. W., and Godfrey, D. G. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Experimental Parasitology 38, 521-534.
17. McCann, P. P., Bacchi, C. J., Hanson, W. L., Cain, G. D., Nathan, H. C., Hutner, S. H., and Sjoerdsma, A. 1981a. Effect on parasitic protozoa of α-difluoromethylornithine - An inhibitor of ornithine decarboxylase. In "Advances in Polyamine Research" (C. M. Caldarera, V. Zappia, and U. Bachrach, Eds.), pp. 97-110. Raven Press, New York.
18. McCann, P. P., Bacchi, C. J., Clarkson, A. B. Jr., Seed, J. R., Nathan, H. C., Amole, B. O., Hutner, S. H., and Sjoerdsma, A. 1981b. Further studies on difluoromethylornithine in African trypanosomes. Medical Biology 59, 434-440.
19. Pepin, J., Milord, F., Mpia, B., Meurice, F., Ethier, L., Degroof, D., and Bruneel, H. 1989. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 514-517.
20. Pospichal, H., Brun, R., Kaminsky, R., and Jenni, L. 1994. Induction of resistance to melarsenoxide cysteamine (MelCy) in Trypanosoma brucei brucei. Acta Tropica 58, 187-197.
21. Raynaud, J. P., Sones, K. R., and Friedheim, E. A. H. 1989. "A Review of Cymelarsan - A New Treatment Proposed for Animal Trypanosomiasis Due to T. evansi and Other Trypanosomes of the T. brucei Group. Pub. no. 115, ISC-TRC, 20th Meeting, Mombasa, Kenya.
22. Ross, C. A., and Barns, A. M. 1996. Alteration to one of three adenosine transporters is associated with resistance to cymelarsan in Trypanosoma evansi. Parasitology Research 82, 183-188.
23. Scott, A. G., Tait, A., and Turner, C. M. R. 1996. Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to melCy and suramin. Acta Tropica 60, 251-262.
24. Van Nieuwenhove, S. 1992. Advances in sleeping sickness therapy. Annales de la Societé Belge de Médecine Tropicale 72(Suppl. 1), 39-51.
25. Williamson, J. 1970. Review of chemotherapeutic and chemoprophylactic agents. In "The African Trypanosomiasis" (H. W. Mulligan, Ed.), pp. 125-224. Allen & Unwin, London.
26. Williamson, J., and Rollo, I. M. 1959. Drug-resistance in trypanosomes: Cross-resistance analyses. British Journal of Pharmacology 14, 423-430.
27. Yarlett, N., Goldberg, B., Nathan, H. C., Garofalo, J., and Bacchi, C. J. 1991. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals. Experimental Parasitology 72, 205-215.